Trial intelligence / Profile preview

RECOTHROM Re-exposure in Surgical Hemostasis

NCT00813904Phase 4Completed

Sponsor
ZymoGenetics
Start
Jan 2009
Primary completion
Jul 2010
Modality
Therapeutic Enzymes
Countries
1
01

Overview

A Phase 4 trial of thrombin alfa, sponsored by ZymoGenetics. Started Jan 2009; status: completed.

02

Drugs

thrombin alfa

Beyond the preview

Go deeper on NCT00813904.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00813904.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call